Filing Details
- Accession Number:
- 0001022079-20-000192
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-11-24 16:31:08
- Reporting Period:
- 2020-11-23
- Accepted Time:
- 2020-11-24 16:31:08
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1022079 | Quest Diagnostics Inc | DGX | Services-Medical Laboratories (8071) | 161387862 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1221534 | Daniel Stanzione | 500 Plaza Drive Secaucus NJ 07094 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2020-11-23 | 5,621 | $125.73 | 33,951 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-11-23 | 3,302 | $126.46 | 30,649 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-11-23 | 2,300 | $127.45 | 28,349 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on October 23, 2020.
- This transaction was executed in multiple trades at prices ranging from $125.09 to $126.04. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $126.09 to $127.08. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $127.12 to $127.88. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Billionaire Hedge Funds
